CCL19-CCR7–dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima (original) (raw)

Change history

In the version of this article initially published, the label along the horizontal axis of the graph in Figure 1a ('Dose (mg)') is incorrect. The correct label is 'Dose (μg)'. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Cybulsky, M.I., Cheong, C. & Robbins, C.S. Macrophages and dendritic cells: partners in atherogenesis. Circ. Res. 118, 637–652 (2016).
    CAS PubMed Google Scholar
  2. Millonig, G. et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 21, 503–508 (2001).
    CAS PubMed Google Scholar
  3. Jongstra-Bilen, J. et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073–2083 (2006).
    CAS PubMed PubMed Central Google Scholar
  4. Choi, J.H. et al. Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves. J. Exp. Med. 206, 497–505 (2009).
    CAS PubMed PubMed Central Google Scholar
  5. Paulson, K.E. et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 106, 383–390 (2010).
    CAS PubMed Google Scholar
  6. Kawai, T. & Akira, S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21, 317–337 (2009).
    CAS PubMed PubMed Central Google Scholar
  7. Soloff, A.C. & Barratt-Boyes, S.M. Enemy at the gates: dendritic cells and immunity to mucosal pathogens. Cell Res. 20, 872–885 (2010).
    CAS PubMed Google Scholar
  8. Martel, C. et al. Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice. J. Clin. Invest. 123, 1571–1579 (2013).
    CAS PubMed PubMed Central Google Scholar
  9. Huttenlocher, A. & Poznansky, M.C. Reverse leukocyte migration can be attractive or repulsive. Trends Cell Biol. 18, 298–306 (2008).
    CAS PubMed PubMed Central Google Scholar
  10. Xu, X. & Ge, Q. Maturation and migration of murine CD4 single positive thymocytes and thymic emigrants. Comput. Struct. Biotechnol. J. 9, e201403003 (2014).
    PubMed PubMed Central Google Scholar
  11. Serbina, N.V. & Pamer, E.G. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat. Immunol. 7, 311–317 (2006).
    CAS PubMed Google Scholar
  12. Fujimura, N. et al. CCR2 inhibition sequesters multiple subsets of leukocytes in the bone marrow. Sci. Rep. 5, 11664 (2015).
    CAS PubMed PubMed Central Google Scholar
  13. Condeelis, J. & Pollard, J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263–266 (2006).
    CAS PubMed Google Scholar
  14. Woodfin, A. et al. The junctional adhesion molecule JAM-C regulates polarized transendothelial migration of neutrophils in vivo. Nat. Immunol. 12, 761–769 (2011).
    CAS PubMed PubMed Central Google Scholar
  15. Campbell, L.A. & Kuo, C.C. _Chlamydia pneumoniae_--an infectious risk factor for atherosclerosis? Nat. Rev. Microbiol. 2, 23–32 (2004).
    CAS PubMed Google Scholar
  16. Grayston, J.T. Infections caused by Chlamydia pneumoniae strain TWAR. Clin. Infect. Dis. 15, 757–761 (1992).
    CAS PubMed Google Scholar
  17. Grayston, J.T. & Campbell, L.A. The role of Chlamydia pneumoniae in atherosclerosis. Clin. Infect. Dis. 28, 993–994 (1999).
    CAS PubMed Google Scholar
  18. Filardo, S., Di Pietro, M., Farcomeni, A., Schiavoni, G. & Sessa, R. _Chlamydia pneumoniae_-mediated inflammation in atherosclerosis: a meta-analysis. Mediators Inflamm. 2015, 378658 (2015).
    PubMed PubMed Central Google Scholar
  19. Zimmer, S., Grebe, A. & Latz, E. Danger signaling in atherosclerosis. Circ. Res. 116, 323–340 (2015).
    CAS PubMed Google Scholar
  20. Moazed, T.C., Kuo, C.C., Grayston, J.T. & Campbell, L.A. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J. Infect. Dis. 177, 1322–1325 (1998).
    CAS PubMed Google Scholar
  21. Gieffers, J. et al. Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103, 351–356 (2001).
    CAS PubMed Google Scholar
  22. Evani, S.J. & Ramasubramanian, A.K. Biophysical regulation of _Chlamydia pneumoniae_-infected monocyte recruitment to atherosclerotic foci. Sci. Rep. 6, 19058 (2016).
    CAS PubMed PubMed Central Google Scholar
  23. Kuo, C.C. et al. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc. Natl. Acad. Sci. USA 92, 6911–6914 (1995).
    CAS PubMed PubMed Central Google Scholar
  24. Kuo, C. & Campbell, L.A. Detection of Chlamydia pneumoniae in arterial tissues. J. Infect. Dis. 181 (Suppl. 3), S432–S436 (2000).
    CAS PubMed Google Scholar
  25. Belland, R.J., Ouellette, S.P., Gieffers, J. & Byrne, G.I. Chlamydia pneumoniae and atherosclerosis. Cell. Microbiol. 6, 117–127 (2004).
    CAS PubMed Google Scholar
  26. Zhu, S.N., Chen, M., Jongstra-Bilen, J. & Cybulsky, M.I. GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions. J. Exp. Med. 206, 2141–2149 (2009).
    CAS PubMed PubMed Central Google Scholar
  27. Gautier, E.L. et al. Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. J. Immunol. 180, 6941–6946 (2008).
    CAS PubMed Google Scholar
  28. Förster, R., Davalos-Misslitz, A.C. & Rot, A. CCR7 and its ligands: balancing immunity and tolerance. Nat. Rev. Immunol. 8, 362–371 (2008).
    PubMed Google Scholar
  29. Nibbs, R.J. & Graham, G.J. Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13, 815–829 (2013).
    PubMed Google Scholar
  30. Gracey, E. et al. Pulmonary Chlamydia muridarum challenge activates lung interstitial macrophages which correlate with IFN-γ production and infection control in mice. Eur. J. Immunol. 45, 3417–3430 (2015).
    CAS PubMed Google Scholar
  31. Rajaram, K. & Nelson, D.E. Chlamydia muridarum infection of macrophages elicits bactericidal nitric oxide production via reactive oxygen species and cathepsin B. Infect. Immun. 83, 3164–3175 (2015).
    CAS PubMed PubMed Central Google Scholar
  32. de Bruijn, M.F. et al. High-level expression of the ER-MP58 antigen on mouse bone marrow hematopoietic progenitor cells marks commitment to the myeloid lineage. Eur. J. Immunol. 26, 2850–2858 (1996).
    CAS PubMed Google Scholar
  33. Choi, J.H. et al. Flt3 signaling-dependent dendritic cells protect against atherosclerosis. Immunity 35, 819–831 (2011).
    CAS PubMed Google Scholar
  34. Link, A. et al. Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat. Immunol. 8, 1255–1265 (2007).
    CAS PubMed Google Scholar
  35. Poznansky, M.C. et al. Thymocyte emigration is mediated by active movement away from stroma-derived factors. J. Clin. Invest. 109, 1101–1110 (2002).
    CAS PubMed PubMed Central Google Scholar
  36. Lee, J.Y., Buzney, C.D., Poznansky, M.C. & Sackstein, R. Dynamic alterations in chemokine gradients induce transendothelial shuttling of human T cells under physiologic shear conditions. J. Leukoc. Biol. 86, 1285–1294 (2009).
    CAS PubMed PubMed Central Google Scholar
  37. Worbs, T., Mempel, T.R., Bölter, J., von Andrian, U.H. & Förster, R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivo. J. Exp. Med. 204, 489–495 (2007).
    CAS PubMed PubMed Central Google Scholar
  38. Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355–360 (2004).
    CAS PubMed Google Scholar
  39. Zachariah, M.A. & Cyster, J.G. Neural crest-derived pericytes promote egress of mature thymocytes at the corticomedullary junction. Science 328, 1129–1135 (2010).
    CAS PubMed PubMed Central Google Scholar
  40. Randolph, G.J., Beaulieu, S., Lebecque, S., Steinman, R.M. & Muller, W.A. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. Science 282, 480–483 (1998).
    CAS PubMed Google Scholar
  41. Weiss, G. & Schaible, U.E. Macrophage defense mechanisms against intracellular bacteria. Immunol. Rev. 264, 182–203 (2015).
    CAS PubMed PubMed Central Google Scholar
  42. van Gils, J.M. et al. The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques. Nat. Immunol. 13, 136–143 (2012).
    CAS PubMed PubMed Central Google Scholar
  43. Angeli, V. et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21, 561–574 (2004).
    CAS PubMed Google Scholar
  44. Park, Y.M., Febbraio, M. & Silverstein, R.L. CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima. J. Clin. Invest. 119, 136–145 (2009).
    CAS PubMed Google Scholar
  45. Llodrá, J. et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl. Acad. Sci. USA 101, 11779–11784 (2004).
    PubMed PubMed Central Google Scholar
  46. Keiper, T. et al. The role of junctional adhesion molecule-C (JAM-C) in oxidized LDL-mediated leukocyte recruitment. FASEB J. 19, 2078–2080 (2005).
    CAS PubMed Google Scholar
  47. Moore, K.J., Sheedy, F.J. & Fisher, E.A. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709–721 (2013).
    CAS PubMed PubMed Central Google Scholar
  48. Daley, J.M., Thomay, A.A., Connolly, M.D., Reichner, J.S. & Albina, J.E. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83, 64–70 (2008).
    CAS PubMed Google Scholar
  49. Ensan, S. et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat. Immunol. 17, 159–168 (2016).
    CAS PubMed Google Scholar

Download references

Acknowledgements

We thank P. Lesnik (University of Pierre and Marie Curie) for CD11c–hBcl-2 mice; M.C. Nussenzweig (The Rockefeller University) for CD11c-eYFP mice; S. Nunes de Vasconcelos (Toronto General Research Institute) for _Rag1_−/− mice; J. Gommerman (University of Toronto) for _Nos2_−/− mouse bones; and N. van Rooijen (Vrije Universiteit) for CLs and PLs. Supported by the Canadian Institutes of Health Research (MOP-84446, MOP-106522 and MOP-89740 to M.I.C.).

Author information

Authors and Affiliations

  1. Toronto General Research Institute, University Health Network, Toronto, Canada
    Mark Roufaiel, Allan Siu, Su-Ning Zhu, Andrew Lau, Hisham Ibrahim, Marwan Althagafi, Kelly Tai, Sharon J Hyduk, Kateryna O Cybulsky, Sherine Ensan, Angela Li, Rickvinder Besla, Henry M Becker, Haiyan Xiao, Clinton S Robbins, Jenny Jongstra-Bilen & Myron I Cybulsky
  2. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada
    Mark Roufaiel, Allan Siu, Hisham Ibrahim, Marwan Althagafi, Rickvinder Besla, Henry M Becker, Clinton S Robbins, Jenny Jongstra-Bilen & Myron I Cybulsky
  3. Krembil Research Institute, University Health Network, Toronto, Canada
    Eric Gracey & Robert D Inman
  4. Department of Immunology, University of Toronto, Toronto, Canada
    Eric Gracey, Kelly Tai, Sherine Ensan, Angela Li, Henry M Becker, Robert D Inman, Clinton S Robbins, Jenny Jongstra-Bilen & Myron I Cybulsky
  5. Department of Biochemistry, Center for Immunity and Infection Lausanne, University of Lausanne, Switzerland
    Sanjiv A Luther
  6. Department of Medicine, University of Toronto, Toronto, Canada
    Robert D Inman

Authors

  1. Mark Roufaiel
  2. Eric Gracey
  3. Allan Siu
  4. Su-Ning Zhu
  5. Andrew Lau
  6. Hisham Ibrahim
  7. Marwan Althagafi
  8. Kelly Tai
  9. Sharon J Hyduk
  10. Kateryna O Cybulsky
  11. Sherine Ensan
  12. Angela Li
  13. Rickvinder Besla
  14. Henry M Becker
  15. Haiyan Xiao
  16. Sanjiv A Luther
  17. Robert D Inman
  18. Clinton S Robbins
  19. Jenny Jongstra-Bilen
  20. Myron I Cybulsky

Contributions

M.R. designed and performed most of the experiments, analyzed the data and contributed to writing the manuscript; E.G. and R.D.I. contributed to experiments with C. muridarum; A.S. and M.A. performed BrdU assays; S.-N.Z. performed ex vivo cannulation and perfusion of the aorta; A. Lau performed TUNEL staining and analysis; H.I. imaged live aortas ex vivo; K.T. performed qPCR analysis of mRNA in the intima; S.J.H. and K.O.C. contributed to function-blocking antibody experiments; S.E., A. Li and R.B. contributed to flow-cytometry sorting studies; H.M.B. contributed to the experimental design and editing; H.X. performed mouse husbandry; S.A.L. provided intellectual input and _Ccl19_−/− BM; C.S.R. provided intellectual input and contributed to flow-cytometry sorting studies; J.J.-B. contributed to the experimental design, project supervision and writing of the manuscript; and M.I.C. provided overall project supervision, including oversight of experiments and writing of the manuscript.

Corresponding author

Correspondence toMyron I Cybulsky.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Quantification of intimal CD11c+ DCs.

Representative composite en face confocal microscopy images of the ascending aortic arch lesser curvature from wild-type mice stained for CD11c (green) and nuclei (blue). Aortas were harvested 24 h after injection of PBS (upper panel) or LPS (lower panel). The abundance of intimal CD11c+ cells is reduced in LPS-injected mice Scale bars, 400 μm.

Supplementary Figure 2 Depletion of circulating monocytes via CLs and apoptosis of CD11c+ DCs in the intima.

(a) Representative flow cytometry plots of blood obtained from wild-type C57BL/6 mice 18 h after i.v. injection of PBS or clodronate liposomes (PL or CL, respectively). Classical monocytes were identified as CD11bhighGr-1+ cells (circled). The CD11bhighGr-1high cells are neutrophils. Absolute numbers of classical monocytes per ml of blood is shown in the graph (mean ± s.e.m.; n = 3; * P < 0.05 (two-tailed Student’s T-test)). (b) Representative en face confocal microscopy images of CD11c-DTR transgenic mouse intima 8 h after injection of DTx (left panel), and wild-type C57BL/6 intima 12 h after LPS injection (right panel). DTx induced extensive apoptosis, which depleted CD11c+ cells, and served as a positive control for TUNEL staining. Only occasional TUNEL+CD11c+ cells were found in the intima of LPS-injected mice (arrowhead). TUNEL+ nuclei (red) CD11c+ cells (green), nuclei (blue). Scale bars, 20 μm.

Supplementary Figure 3 Establishing the efficacy of function-blocking antibodies.

(a) In vitro CD8+ T cell chemotaxis assays. CD8+ T cells were purified from wild-type mouse lymph nodes. A chemotactic gradient was established by adding recombinant murine CCL21 (100 nM) to the bottom wells of a chemotactic chamber. T cells in the top wells were incubated with function-blocking antibodies to CCL21 or CCL19, or isotype-matched IgG. Three independent experiments were performed, each with triplicate wells. Values were normalized to the IgG-treated control group. mean ± s.e.m. ** P < 0.01 (one-way ANOVA with Tukey’s comparison). (b) In vivo adoptive transfer of UBC-GFP lymph node cells into wild-type and plt mice. One hour before the adoptive transfer, mice were injected with function-blocking antibody to CCL19 or CCL21, or isotype-matched IgG. Two hours after adoptive transfer, blood, spleen, and lymph nodes were isolated, cell suspensions were stained for CD3 and CD4 and analyzed by flow cytometry. Values represent GFP+CD4+ T cells (that were gated from CD3+ events in lymph nodes) relative to wild-type mice injected with IgG. Data were normalized to blood and spleen values in order to control for variability in adoptive transfer efficiency. ** P < 0.01, *** P < 0.001 (one-way ANOVA with Tukey’s comparison). Data are from three independent experiments (mean ± s.e.m. (a,b)).

Supplementary Figure 4 Determining the dose of Chlamydia in intranasal and i.v. inoculation models.

(a) Wild-type mice received an intranasal inoculation of C. muridarum. The dose, shown as inclusion forming units (IFU), is indicated. C. muridarum 16s rRNA expression in blood leukocytes was determined by qPCR 2.5 days after inoculation. Comparable infection of blood leukocytes is observed. The lower dose was selected for future studies. (b) Wild-type mice were injected i.v. with the indicated dose of C. muridarum and intimal CD11c+ cells per ascending aorta were quantified at 24 h. The highest dose was selected since it induces the greatest decrease in intimal CD11c+ cells. (c) The maximal Chlamydia infection in the intima was comparable after intranasal and i.v. injections. *** P < 0.001 (two-tailed Student’s T-test (a,c), one-way ANOVA with Tukey’s comparison (b)). Data are from three independent experiments (mean + s.e.m. (a-c)).

Supplementary Figure 5 IL-1β and TNF induce a decrease in intimal CD11c+ cells.

(a, c) In vivo assays: Cytokines were injected i.v. at the indicated doses and intimal CD11c+ cells per ascending aorta were quantified at 24 h. (b, d) Ex vivo assays: Ascending aortas were incubated with different concentrations of cytokines and intimal CD11c+ cells were determined at 12 h. ** P < 0.01, *** P < 0.001 (one-way ANOVA with Tukey’s comparison (a,c), two-tailed Student’s T-test (b,d)). Data are from three independent experiments (mean + s.e.m. (a-d)).

Supplementary Figure 6 Detection of C. muridarum in the plasma and blood leukocytes.

(a) Wild-type C57BL/6 mice were injected with PBS liposomes (PL) or clodronate liposomes (CL) 12 h prior to C. muridarum (107 EB i.v. per mouse). Blood was collected at 24 h after C. muridarum injection, cells were removed by centrifugation, and elementary bodies in the plasma were enumerated by assessing IFU in fibroblast cultures. mean ± s.e.m.; n = 10 for PL and n =5 for CL; *** P < 0.001 (two-tailed Student’s T-test). (b) Representative flow cytometry plots showing the sorting strategy for isolating blood B cells, T cells, neutrophils, classical and non-classical monocytes. Blood samples were obtained from wild-type mice 24 h after i.v. injection of C. muridarum and cells were stained for CD3, B220, Gr-1, and CD11b. The CD3- B220- gate from the upper plot was analyzed for Gr-1 and CD11b in the lower plot. Cells were sorted directly into Trizol reagent for RNA isolation and detection of C. muridarum 16s rRNA. Plots are from one experiment representative of three experiments (n = 6 mice).

Supplementary Figure 7 RTM of intimal CD11c+ cells removes C. muridarum from the arterial intima.

(a) Assessment of C. muridarum EB clearance from the plasma of _Ccr7_-/- and wild-type (WT) mice after i.v. injection of C. muridarum EBs (107 IFU per mouse). (b,c) Quantification of C. muridarum 16s rRNA by qPCR in blood leukocytes (b) and splenocytes (c) of wild-type and _Ccr7_-/- mice (key) after i.v. injection of C. muridarum EBs.. Data are expressed relative to values on day 1, set as 1. (d) Quantification of C. muridarum 16s rRNA in BM-derived macrophages after infection in vitro with C. muridarum EBs.. Data are expressed relative to 6 h values in wild-type cells. (e) Quantification of C. muridarum 16s rRNA in the intima (left) and the number of intimal CD11c+ cells (right) in wild-type mice injected i.v. with C. muridarum EBs on day 0 and PTx or B-oligomer on day 3. Aortas were analyzed on days 3 and 4. (f) Assessment of systemic inflammatory response after C. muridarum infection. Wild-type (dashed red) and _Ccr7_-/- (solid blue) mice were injected i.v. with C. muridarum EBs on day 0 and daily blood samples were collected for serum analysis. Cytokines and chemokines were analyzed using a LUMINEX MULTIPLEX ELISA. IL-3, IL-4, IL-17, and VEGF were not detectable in mouse serum. (g) Quantification of intimal CD11c+ cells in wild-type mice reconstituted with wild-type (WT) or _Nos2_-/- BM (key). After engraftment, mice were injected i.v. with C. muridarum EBs and intimal CD11c+ cells were quantified at the indicated time points by confocal microscopy.. (h) Quantification of intimal CD11c+ cells in wild-type mice injected i.v. with C. muridarum EBs and either iNOS inhibitor 1400W (10 mg/kg, i.v. 24 h prior to tissue harvesting) or DMSO (carrier control). (i) Quantification of intimal CD3+ cells in wild-type mice at the indicated time points after i.v. injection of C. muridarum EBs. (j ) Quantification of C. muridarum 16s rRNA in the intima of CD11c-DTR mice on day 3 after i.v. injection of C. muridarum EBs and depletion of intimal CD11c+ cells by injecting DTx on day 2. Controls received PBS instead of DT. (k) Quantification of C. muridarum 16s rRNA in the intima of CD11c-hBcl2 mice on days 3 and 4 after i.v. injection of C. muridarum EBs. (l) PCR analysis of mRNA in the aortic intima of wild-type (red) and _Ccr7_-/- (blue) mice at various times after i.v. injection of C. muridarum EBs. Data are expressed relative to values on day 0, set as 1..* P < 0.05, ** P < 0.01, *** P < 0.001 (one-way ANOVA (i) with Tukey’s post hoc test (c,d,e,g,h), two-way ANOVA (b) with Bonferroni’s post-hoc comparisons (f,l)), or unpaired Student’s t-test (a,j,k)). Data are from three independent experiments (a-l; mean ± s.e.m.).

Supplementary Figure 8 Hypercholesterolemia inhibits RTM induced by TLR4 ligands.

Quantification of intimal CD11c+ cells in _Ldlr_-/- mice (10 – 12 weeks old) that were fed either SCD or CRD for 1 week (key), then injected i.v. with PBS, LPS (100 μg) or poly(I:C) (150 μg), and aortas were harvested after 24 h. mean ± s.e.m.; n = 5 mice per group; *** P < 0.001 (one-way ANOVA (P < 0.0001) with Tukey’s comparison (within each diet group); two-way ANOVA (P = 0.0001) with Bonferroni’s comparison (between diet groups)). Data are from three independent experiments.

Supplementary information

Source data

Rights and permissions

About this article

Cite this article

Roufaiel, M., Gracey, E., Siu, A. et al. CCL19-CCR7–dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima.Nat Immunol 17, 1263–1272 (2016). https://doi.org/10.1038/ni.3564

Download citation